163 related articles for article (PubMed ID: 1454455)
1. Recommendations for intravenous immunoglobulin therapy of Kawasaki disease.
Shulman ST
Pediatr Infect Dis J; 1992 Nov; 11(11):985-6. PubMed ID: 1454455
[No Abstract] [Full Text] [Related]
2. The mechanism of efficacy of intravenous immunoglobulin in Kawasaki disease.
Kaneka K; Savage CO; Pottinger BE; Shah V; Pearson JD; Dillon MJ
Pediatr Infect Dis J; 1994 Nov; 13(11):1022-3. PubMed ID: 7845731
[No Abstract] [Full Text] [Related]
3. Kawasaki disease--treatment with intravenous immunoglobulin during the acute stage.
Singh S; Kumar L
Indian Pediatr; 1996 Aug; 33(8):689-92. PubMed ID: 8979554
[No Abstract] [Full Text] [Related]
4. Treatment of Kawasaki disease.
Glode MP; Burns JC
Pediatr Infect Dis J; 1992 Mar; 11(3):249-50. PubMed ID: 1565549
[No Abstract] [Full Text] [Related]
5. [New aspects of therapy in Kawasaki disease].
Keren G; Ballin A
Harefuah; 1994 Jun; 126(11):667-71. PubMed ID: 7927003
[No Abstract] [Full Text] [Related]
6. Changes in BAFF/APRIL levels in a 2-year-old girl with Kawasaki disease refractory to intravenous immunoglobulin therapy.
Yoshida S; Sakurai Y; Takeda T; Fukuda K
J Investig Allergol Clin Immunol; 2013; 23(1):52-3. PubMed ID: 23653975
[No Abstract] [Full Text] [Related]
7. IVIG, aspirin, and Kawasaki disease.
Morgan GJ; MacLeod C; Jenkins J; Stewart C; Craig B
J Pediatr; 2003 Aug; 143(2):280-1; author reply 281. PubMed ID: 12970651
[No Abstract] [Full Text] [Related]
8. [Kawasaki disease--two case reports].
Mroczkowska-Juchniewicz A; Moszyńska B; Pawłowska-Kamieniak A; Szczepanowska A; Papierkowski A
Pol Merkur Lekarski; 1997 Jul; 3(13):20-1. PubMed ID: 9432293
[TBL] [Abstract][Full Text] [Related]
9. Kawasaki disease in Calcutta.
Paul DK; Gupta A; Lahiri M
Indian Pediatr; 2000 Nov; 37(11):1264-5. PubMed ID: 11086312
[No Abstract] [Full Text] [Related]
10. Treatment of a Jehovah's Witness with immune globulin: case of a child with Kawasaki syndrome.
Roy-Bornstein C; Sagor LD; Roberts KB
Pediatrics; 1994 Jul; 94(1):112-3. PubMed ID: 8008516
[No Abstract] [Full Text] [Related]
11. Immune supplementation and immune modulation with intravenous immunoglobulin.
Mazer BD; Al-Tamemi S; Yu JW; Hamid Q
J Allergy Clin Immunol; 2005 Oct; 116(4):941-4. PubMed ID: 16210080
[No Abstract] [Full Text] [Related]
12. Severe dyshidrotic eczema after intravenous immunoglobulin therapy for Kawasaki syndrome.
Shiraishi T; Yamamoto T
Pediatr Dermatol; 2013; 30(3):e30-1. PubMed ID: 22304420
[TBL] [Abstract][Full Text] [Related]
13. Kawasaki disease.
Narayanan SN; Krishnaveni ; Sabarinathan K
Indian Pediatr; 1997 Feb; 34(2):139-43. PubMed ID: 9255010
[No Abstract] [Full Text] [Related]
14. VI nerve palsy after intravenous immunoglobulin in Kawasaki disease.
Rodríguez-Lozano A; Juárez-Echenique JC; Rivas-Larrauri F; Gámez-González LB; Yamazaki-Nakashimada M
Allergol Immunopathol (Madr); 2014; 42(1):82-3. PubMed ID: 23340202
[No Abstract] [Full Text] [Related]
15. Cerebral infarction after high-dose intravenous immunoglobulin therapy for Kawasaki disease.
Wada Y; Kamei A; Fujii Y; Ishikawa K; Chida S
J Pediatr; 2006 Mar; 148(3):399-400. PubMed ID: 16615977
[TBL] [Abstract][Full Text] [Related]
16. Adult Kawasaki disease: evaluating the fluctuation of circulating lymphocytes associated with i.v. immunoglobulin treatment.
Fujimoto N; Teramura K; Tanaka T
J Dermatol; 2012 Nov; 39(11):957-8. PubMed ID: 22390144
[No Abstract] [Full Text] [Related]
17. Kawasaki disease: an overview.
Pinna GS; Kafetzis DA; Tselkas OI; Skevaki CL
Curr Opin Infect Dis; 2008 Jun; 21(3):263-70. PubMed ID: 18448971
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of plasma exchange therapy for Kawasaki disease by cytokine profiling.
Kashiwagi Y; Kawashima H; Akamatsu N; Morishima Y; Nishimata S
Ther Apher Dial; 2012 Jun; 16(3):281-3. PubMed ID: 22607573
[No Abstract] [Full Text] [Related]
19. Diagnosis and management of children with Kawasaki disease.
Gidding SS; Shulman ST
Heart Dis Stroke; 1994; 3(4):210-5. PubMed ID: 7921666
[TBL] [Abstract][Full Text] [Related]
20. A report of two cases of Kawasaki disease treated with plasma exchange.
Harada T; Ito S; Shiga K; Inaba A; Machida H; Aihara Y; Yokota S
Ther Apher Dial; 2008 Apr; 12(2):176-9. PubMed ID: 18387169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
